Cyclophosphamide
Idiopathic Pulmonary Fibrosis
Clinical trials
2
Developer
Assistance Publique - Hôpitaux de Paris
Overview
Cyclophosphamide is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 2 tracked IPF clinical trials.
Cyclophosphamide clinical trials
Explore related
Medical disclaimer. This page summarizes research about Cyclophosphamide for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.